Form 10-Q · Quarterly report
UnitedHealth Group 10-Q, filed Aug 10, 2026
- Filed
- CIK
- 0000731766
- Accession no.
- 0000731766-26-000197
Summary
UnitedHealth Group reported second-quarter 2026 revenue of $112.0 billion, essentially flat year over year, and earnings from operations of $8.0 billion, up from $5.2 billion, with diluted earnings per common share of $6.04. The company served 1.6 million fewer people and cited pressure on Medicare Advantage funding and elevated commercial medical cost trends.
Key points
- Second-quarter 2026 total revenues were $112.0 billion, essentially unchanged from $111.6 billion a year earlier; net earnings rose to $5.7 billion from $3.6 billion.
- UnitedHealthcare served 1.6 million fewer people due to benefit design and pricing actions, reduced Medicaid eligibility, and an exit from one state.
- Optum revenue fell 2% while UnitedHealthcare revenue was flat; cash flows from operations for the first half of 2026 were $20.0 billion.
- UnitedHealth Group recorded a $39 million net loss on portfolio divestitures in the second quarter and a $191 million net gain for the first half, and said Medicare Advantage rate notices and risk-adjustment revisions continue to pressure funding.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION EXECUTIVE OVERVIEW General UnitedHealth Group is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. Our two distinct, yet complementary businesses — Optum and UnitedHealthcare — are working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences for the individuals and organizations we are privileged to serve. We have four reportable segments: •Optum Health; •Optum Insight; •Optum Rx; …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.